Screener
Arvinas ARVN R&D
R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arvinas in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Arvinas’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 5:18 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033669
| (dollars and shares in millions, except per share amounts) / Consolidated Statements of Operations | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $15.6 | $188.8 |
| Operating expenses: | ||
| Research and development | 60.3 | 90.8 |
| General and administrative | 19.1 | 26.6 |
| Total operating expenses | 79.4 | 117.4 |
| (Loss) income from operations | (63.8) | 71.4 |
| Other income | ||
| Other expense, net | (0.1) | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arvinas's R&D?
- Arvinas (ARVN) reported R&D of $60.3M in Q1 2026.
- How has Arvinas's R&D changed year-over-year?
- Arvinas's R&D decreased by 33.6% year-over-year, from $90.8M to $60.3M.
- What is the long-term trend for Arvinas's R&D?
- Over 4 years (2021 to 2025), Arvinas's R&D has grown at a 12.1% compound annual growth rate (CAGR), from $180.4M to $285.2M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Arvinas's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude